Accelerate biotechnology

Manufacturing

To confirm scalability of the production processes in development stage into higher scale production processes, Batavia Biosciences operates a BSL-II GMP manufacturing facility.

The facility is equipped to run up to 200 Liter mammalian cell line based processes and is fully licensed to manufacture inactivated and live attenuated viral vaccines, viral vectors as well as recombinant proteins and antibodies. In this facility we also frequently manufacture GMP-grade Master and Working Cell Banks and Master and Working Virus Seeds.

To enable the quality release of clinical drug substance or drug product, the Batavia Biosciences expert Quality team includes a Qualified Person (QP), a GMP QA system and a QC department.

Virus & Cell banking

Virus and Cell Banking Services

Clinical Material Production

Clinical Material Production in GMP

GMP Release

GMP Release and Stability Studies

Manufacturing & Regulatory Support